Brian Kirby

31PUBLICATIONS

80CO-AUTHORS

Major global burdens of diseaseCardiology (incl. cardiovascular diseases)Gene and molecular therapyInnate immunityAerospace engineering not elsewhere classified

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (31)

Sort by Publication Date:

|Jun 15, 2026

A Systematic Review of the Clinical Impact of GLP-1 Receptor Agonists in Hidradenitis Suppurativa.

|Nov 22, 2025

Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals.

Raymond Matthews, April W Armstrong, Matthias Augustin

|May 17, 2025

Hidradenitis suppurativa and mortality in Ireland over a 10-year period: an assessment of statistics and review of the literature.

Emily K Pender, Rosalind Hughes, Brian Kirby

|Aug 14, 2024

Treatment of hidradenitis suppurativa with adalimumab in the PIONEER I and II randomized controlled trials reduced indices of systemic inflammation, recognized risk factors for cardiovascular disease.

Niamh Kearney, Xin Chen, Yingtao Bi

|Aug 01, 2024

GRAPPA Point-Counterpoint: Should Biologics Be Used for Mild Psoriasis?

Gretchen D Ball, Hassan Hamade, Alice B Gottlieb

|Feb 02, 2024

Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study.

Hans Christian Ring, Jonathan Thorsen, Brian Kirby

Pageof 6

Frequent Collaborators

10 joint publications

Niamh Kearney

Roisin Hambly

Jean M Fletcher

Emily Pender

Andreea Petrasca

John R Ingram

Shivashini Kirthi

Conor M Smith

Linnea Thorlacius

Christopher Sayed

Frequent Collaborators

10 joint publications

Niamh Kearney

7 joint publications

Roisin Hambly

6 joint publications

Jean M Fletcher

3 joint publications

Emily Pender